Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
425 USD | -1.14% | +3.67% | +4.52% |
11:53am | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
05-10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.52% | 111B | |
+11.12% | 105B | |
-12.01% | 22.34B | |
-3.78% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-9.23% | 16.96B | |
+3.09% | 13.7B | |
+37.04% | 12.45B | |
+291.78% | 7.98B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated, Q4 2018 Earnings Call, Feb 05, 2019